Edda Blumel
Overview
Explore the profile of Edda Blumel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knoll R, Bonaguro L, Dos Santos J, Warnat-Herresthal S, Jacobs-Cleophas M, Blumel E, et al.
Front Immunol
. 2023 Dec;
14:1275136.
PMID: 38077315
Introduction: People living with HIV (PLHIV) are characterized by functional reprogramming of innate immune cells even after long-term antiretroviral therapy (ART). In order to assess technical feasibility of omics technologies...
2.
Gluud M, Pallesen E, Buus T, Gjerdrum L, Lindahl L, Kamstrup M, et al.
Blood
. 2022 Sep;
141(2):180-193.
PMID: 36122387
Cutaneous T-cell lymphoma (CTCL) is a devastating lymphoid malignancy characterized by the accumulation of malignant T cells in the dermis and epidermis. Skin lesions cause serious symptoms that hamper quality...
3.
Willerslev-Olsen A, Buus T, Nastasi C, Blumel E, Gluud M, Bonefeld C, et al.
Blood Cancer J
. 2020 May;
10(5):57.
PMID: 32409671
Sézary syndrome (SS) is a heterogeneous leukemic subtype of cutaneous T-cell lymphoma (CTCL) with generalized erythroderma, lymphadenopathy, and a poor prognosis. Advanced disease is invariably associated with severe immune dysregulation...
4.
Blumel E, Ahmad S, Nastasi C, Willerslev-Olsen A, Gluud M, Fredholm S, et al.
Oncoimmunology
. 2020 May;
9(1):1751561.
PMID: 32363124
and its toxins have been linked to disease progression and mortality in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8 T cells play a crucial role in anti-cancer responses and...
5.
Gluud M, Fredholm S, Blumel E, Willerslev-Olsen A, Buus T, Nastasi C, et al.
Dermatology
. 2020 Apr;
237(2):277-282.
PMID: 32335549
Background: Mycosis fungoides (MF), the most common form of cutaneous T-cell lymphoma (CTCL), is a lymphoproliferative disorder characterized by proliferation of malignant T cells in a chronic inflammatory environment in...
6.
Blumel E, Willerslev-Olsen A, Gluud M, Lindahl L, Fredholm S, Nastasi C, et al.
Oncoimmunology
. 2019 Oct;
8(11):e1641387.
PMID: 31646088
is implicated in disease progression in cutaneous T-cell lymphoma (CTCL). Here, we demonstrate that malignant T cell lines derived from CTCL patients as well as primary malignant CD4 T cells...
7.
Hu T, Krejsgaard T, Nastasi C, Buus T, Nansen A, Hald A, et al.
Dermatology
. 2019 Sep;
236(2):123-132.
PMID: 31536992
Background: The voltage-gated potassium channel Kv1.3 (KCNA3) is expressed by effector memory T cells (TEM) and plays an important role in their activation and proliferation. Mycosis fungoides (MF), the most...
8.
Hu T, Buus T, Krejsgaard T, Nansen A, Lundholt B, Spee P, et al.
Oncotarget
. 2019 Aug;
10(47):4894-4906.
PMID: 31448055
The voltage-gated potassium channel Kv1.3 (KCNA3) is expressed by a subset of chronically activated memory T cells and plays an important role in their activation and proliferation. Here, we show...
9.
Lindahl L, Willerslev-Olsen A, Gjerdrum L, Nielsen P, Blumel E, Rittig A, et al.
Blood
. 2019 Jul;
134(13):1072-1083.
PMID: 31331920
It has been proposed that CD4 T-cell responses to (SA) can inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T-cell lymphoma (CTCL). In this prospective study, we...
10.
Buus T, Willerslev-Olsen A, Fredholm S, Blumel E, Nastasi C, Gluud M, et al.
Blood Adv
. 2018 Aug;
2(16):2115-2126.
PMID: 30139925
Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) with a median life expectancy of less than 4 years. Although initial treatment responses are often good,...